BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 31024855)

  • 61. Multiparametric MRI-Based Radiomics Nomogram for Predicting Lymph Node Metastasis in Early-Stage Cervical Cancer.
    Xiao M; Ma F; Li Y; Li Y; Li M; Zhang G; Qiang J
    J Magn Reson Imaging; 2020 Sep; 52(3):885-896. PubMed ID: 32096586
    [TBL] [Abstract][Full Text] [Related]  

  • 62. CT-based radiomics signature analysis for evaluation of response to induction chemotherapy and progression-free survival in locally advanced hypopharyngeal carcinoma.
    Liu X; Long M; Sun C; Yang Y; Lin P; Shen Z; Xia S; Shen W
    Eur Radiol; 2022 Nov; 32(11):7755-7766. PubMed ID: 35608663
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Dual-region radiomics signature: Integrating primary tumor and lymph node computed tomography features improves survival prediction in esophageal squamous cell cancer.
    Lu N; Zhang WJ; Dong L; Chen JY; Zhu YL; Zhang SH; Fu JH; Yin SH; Li ZC; Xie CM
    Comput Methods Programs Biomed; 2021 Sep; 208():106287. PubMed ID: 34311416
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Novel prognostic nomograms to assess survival in high-grade serous ovarian carcinoma after surgery and chemotherapy: a retrospective cohort study from SEER database.
    Huang W; Bao Y; Luo X; Yao L; Yuan L
    Ann Transl Med; 2022 Jul; 10(13):728. PubMed ID: 35957727
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Development and validation of a contrast-enhanced CT-based radiomics nomogram for preoperative diagnosis in neuroendocrine carcinoma of digestive system.
    Xu L; Yang X; Xiang W; Hu P; Zhang X; Li Z; Li Y; Liu Y; Dai Y; Luo Y; Qiu H
    Front Endocrinol (Lausanne); 2023; 14():1155307. PubMed ID: 37124722
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Radiomic signature of
    Jiang Y; Yuan Q; Lv W; Xi S; Huang W; Sun Z; Chen H; Zhao L; Liu W; Hu Y; Lu L; Ma J; Li T; Yu J; Wang Q; Li G
    Theranostics; 2018; 8(21):5915-5928. PubMed ID: 30613271
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Validation analysis of the novel imaging-based prognostic radiomic signature in patients undergoing primary surgery for advanced high-grade serous ovarian cancer (HGSOC).
    Fotopoulou C; Rockall A; Lu H; Lee P; Avesani G; Russo L; Petta F; Ataseven B; Waltering KU; Koch JA; Crum WR; Cunnea P; Heitz F; Harter P; Aboagye EO; du Bois A; Prader S
    Br J Cancer; 2022 Apr; 126(7):1047-1054. PubMed ID: 34923575
    [TBL] [Abstract][Full Text] [Related]  

  • 68. MRI-based multiregional radiomics for predicting lymph nodes status and prognosis in patients with resectable rectal cancer.
    Li H; Chen XL; Liu H; Lu T; Li ZL
    Front Oncol; 2022; 12():1087882. PubMed ID: 36686763
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Preoperative computed tomography enterography-based radiomics signature: A potential predictor of postoperative anastomotic recurrence in patients with Crohn's disease.
    Shen XD; Zhang RN; Huang SY; Wang YD; Liu RY; Meng JX; Zhou J; Chen Z; Fang JY; Mao R; Li ZP; Sun CH; Feng ST; Lin SC; Zhong YK; Li XH
    Eur J Radiol; 2023 May; 162():110766. PubMed ID: 36924538
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A Comprehensive Nomogram Combining CT Imaging with Clinical Features for Prediction of Lymph Node Metastasis in Stage I-IIIB Non-small Cell Lung Cancer.
    Zheng X; Shao J; Zhou L; Wang L; Ge Y; Wang G; Feng F
    Ther Innov Regul Sci; 2022 Jan; 56(1):155-167. PubMed ID: 34699046
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Development and validation of prognostic gene signature for basal-like breast cancer and high-grade serous ovarian cancer.
    Zhang Y; Liu J; Raj-Kumar PK; Sturtz LA; Praveen-Kumar A; Yang HH; Lee MP; Fantacone-Campbell JL; Hooke JA; Kovatich AJ; Shriver CD; Hu H
    Breast Cancer Res Treat; 2020 Dec; 184(3):689-698. PubMed ID: 32880016
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Discovery and Validation of a CT-Based Radiomic Signature for Preoperative Prediction of Early Recurrence in Hypopharyngeal Carcinoma.
    Li W; Wei D; Wushouer A; Cao S; Zhao T; Yu D; Lei D
    Biomed Res Int; 2020; 2020():4340521. PubMed ID: 32851071
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A Clinical-Radiomics Nomogram Based on Computed Tomography for Predicting Risk of Local Recurrence After Radiotherapy in Nasopharyngeal Carcinoma.
    Zhu C; Huang H; Liu X; Chen H; Jiang H; Liao C; Pang Q; Dang J; Liu P; Lu H
    Front Oncol; 2021; 11():637687. PubMed ID: 33816279
    [No Abstract]   [Full Text] [Related]  

  • 74. Preoperative Radiomics Analysis of Contrast-Enhanced CT for Microvascular Invasion and Prognosis Stratification in Hepatocellular Carcinoma.
    Xu T; Ren L; Liao M; Zhao B; Wei R; Zhou Z; He Y; Zhang H; Chen D; Chen H; Liao W
    J Hepatocell Carcinoma; 2022; 9():189-201. PubMed ID: 35340666
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A Metabolism-Related Radiomics Signature for Predicting the Prognosis of Colorectal Cancer.
    Cai D; Duan X; Wang W; Huang ZP; Zhu Q; Zhong ME; Lv MY; Li CH; Kou WB; Wu XJ; Gao F
    Front Mol Biosci; 2020; 7():613918. PubMed ID: 33490106
    [No Abstract]   [Full Text] [Related]  

  • 76. Development of a Novel, Multi-Parametric, MRI-Based Radiomic Nomogram for Differentiating Between Clinically Significant and Insignificant Prostate Cancer.
    Zhang Y; Chen W; Yue X; Shen J; Gao C; Pang P; Cui F; Xu M
    Front Oncol; 2020; 10():888. PubMed ID: 32695660
    [No Abstract]   [Full Text] [Related]  

  • 77. Development of MRI-Based Radiomics Model to Predict the Risk of Recurrence in Patients With Advanced High-Grade Serous Ovarian Carcinoma.
    Li HM; Gong J; Li RM; Xiao ZB; Qiang JW; Peng WJ; Gu YJ
    AJR Am J Roentgenol; 2021 Sep; 217(3):664-675. PubMed ID: 34259544
    [No Abstract]   [Full Text] [Related]  

  • 78. CT-based radiomics nomogram analysis for assessing BRCA mutation status in patients with high-grade serous ovarian cancer.
    Cao Y; Jiang Y; Song J; Zhang A; Duan S; Chen T; Wu F; Cheng W
    Acta Radiol; 2023 Oct; 64(10):2802-2811. PubMed ID: 37553913
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Establishment and validation of novel MRI radiomic feature-based prognostic models to predict progression-free survival in locally advanced rectal cancer.
    Xie F; Zhao Q; Li S; Wu S; Li J; Li H; Chen S; Jiang W; Dong A; Wu L; Liu L; Huang H; Xu S; Shao Y; Liu L; Li L; Cai P
    Front Oncol; 2022; 12():901287. PubMed ID: 36408187
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A Radiomic Nomogram for the Ultrasound-Based Evaluation of Extrathyroidal Extension in Papillary Thyroid Carcinoma.
    Wang X; Agyekum EA; Ren Y; Zhang J; Zhang Q; Sun H; Zhang G; Xu F; Bo X; Lv W; Hu S; Qian X
    Front Oncol; 2021; 11():625646. PubMed ID: 33747941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.